CATALYST PHARMACEUTICALS INC's ticker is CPRX and the CUSIP is 14888U101. A total of 51 filers reported holding CATALYST PHARMACEUTICALS INC in Q4 2014. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2015 | $90,000 | -27.4% | 30,000 | 0.0% | 0.04% | -15.6% |
| Q2 2015 | $124,000 | -4.6% | 30,000 | 0.0% | 0.04% | -10.0% |
| Q1 2015 | $130,000 | +46.1% | 30,000 | 0.0% | 0.05% | +28.2% |
| Q4 2014 | $89,000 | -11.0% | 30,000 | 0.0% | 0.04% | -20.4% |
| Q3 2014 | $100,000 | +31.6% | 30,000 | 0.0% | 0.05% | +32.4% |
| Q2 2014 | $76,000 | +11.8% | 30,000 | 0.0% | 0.04% | -9.8% |
| Q1 2014 | $68,000 | +15.3% | 30,000 | 0.0% | 0.04% | +17.1% |
| Q4 2013 | $59,000 | – | 30,000 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Consonance Capital Management LP | 5,517,885 | $22,789,000 | 2.29% |
| March Altus Capital Management LP | 80,890 | $334,000 | 1.94% |
| TANAKA CAPITAL MANAGEMENT INC | 111,693 | $462,000 | 1.15% |
| PURA VIDA INVESTMENTS, LLC | 395,000 | $1,951,000 | 1.00% |
| Broadfin Capital, LLC | 4,183,177 | $17,277,000 | 0.93% |
| Catalyst Capital Advisors LLC | 1,310,000 | $5,411,000 | 0.63% |
| SPHERA FUNDS MANAGEMENT LTD. | 1,200,000 | $4,956,000 | 0.48% |
| Baker Brothers Advisors | 7,335,692 | $30,296,000 | 0.27% |
| TURNER INVESTMENTS LLC | 286,370 | $1,183,000 | 0.22% |
| Perceptive Advisors | 851,200 | $3,515,000 | 0.21% |